APO Research
Talk to an analyst

APO RESEARCH · REPORT

Retail Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Retail Drug Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchRetail Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Retail Drug Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Retail Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Retail Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Retail Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Retail Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Retail Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Retail Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Retail Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Retail Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Retail Drug market include CVS Caremark, Rite Aid, Target, Walgreens and Walmart, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Retail Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Retail Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Retail Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Retail Drug market.

Retail Drug Segment by Company

CVS Caremark

Rite Aid

Target

Walgreens

Walmart

Retail Drug Segment by Type

Generic Drug

OTC Drug

Others

Retail Drug Segment by Application

Hospital

Clinic

Hoem Use

Retail Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Retail Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Retail Drug key companies, revenue, market share, and recent developments.

3. To split the Retail Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Retail Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Retail Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Retail Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retail Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Retail Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retail Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Retail Drug industry.

Chapter 3: Detailed analysis of Retail Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Retail Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Retail Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Retail Drug Industry Trends Table 2. Retail Drug Industry Drivers Table 3. Retail Drug Industry Opportunities and Challenges Table 4. Retail Drug Industry Restraints Table 5. Global Retail Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Retail Drug Revenue Share by Company (2021-2026) Table 7. Global Retail Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Retail Drug Key Company Manufacturing Base & Headquarters Table 9. Global Retail Drug Company, Product Type & Application Table 10. Global Retail Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Retail Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Generic Drug Table 15. Significant Companies of OTC Drug Table 16. Significant Companies of Others Table 17. Global Retail Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Retail Drug Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Retail Drug Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Retail Drug Sales Value Share by Type (2021-2026) Table 21. Global Retail Drug Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Clinic Table 24. Significant Companies of Hoem Use Table 25. Global Retail Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Retail Drug Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Retail Drug Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Retail Drug Sales Value Share by Application (2021-2026) Table 29. Global Retail Drug Sales Value Share by Application (2027-2032) Table 30. Global Retail Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Retail Drug Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Retail Drug Sales Value Share by Region (2021-2026) Table 33. Global Retail Drug Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Retail Drug Sales Value Share by Region (2027-2032) Table 35. Global Retail Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Retail Drug Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Retail Drug Sales Value Market Share by Country (2021-2026) Table 38. Global Retail Drug Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Retail Drug Sales Value Market Share by Country (2027-2032) Table 40. CVS Caremark Company Information Table 41. CVS Caremark Business Overview Table 42. CVS Caremark Retail Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. CVS Caremark Retail Drug Product Portfolio Table 44. CVS Caremark Recent Development Table 45. Rite Aid Company Information Table 46. Rite Aid Business Overview Table 47. Rite Aid Retail Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Rite Aid Retail Drug Product Portfolio Table 49. Rite Aid Recent Development Table 50. Target Company Information Table 51. Target Business Overview Table 52. Target Retail Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Target Retail Drug Product Portfolio Table 54. Target Recent Development Table 55. Walgreens Company Information Table 56. Walgreens Business Overview Table 57. Walgreens Retail Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Walgreens Retail Drug Product Portfolio Table 59. Walgreens Recent Development Table 60. Walmart Company Information Table 61. Walmart Business Overview Table 62. Walmart Retail Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Walmart Retail Drug Product Portfolio Table 64. Walmart Recent Development Table 65. Research Programs/Design for This Report Table 66. Authors List of This Report Table 67. Secondary Sources Table 68. Primary Sources List of Figures Figure 1. Retail Drug Product Image Figure 2. Global Retail Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Retail Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Retail Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Generic Drug Image Figure 8. OTC Drug Image Figure 9. Others Image Figure 10. Global Retail Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Retail Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Retail Drug Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Hoem Use Image Figure 16. Global Retail Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Retail Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Retail Drug Sales Value Share by Application (2021-2032) Figure 19. Global Retail Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Retail Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Retail Drug Sales Value (2021-2032) & (US$ Million) Figure 22. North America Retail Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Retail Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Retail Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Retail Drug Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Retail Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Retail Drug Sales Value (2021-2032) & (US$ Million) Figure 28. South America Retail Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Retail Drug Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Retail Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Retail Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Retail Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Retail Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • OTC Drug
  • Others
Applications
  • Hospital
  • Clinic
  • Hoem Use
Companies covered
  • CVS Caremark
  • Rite Aid
  • Target
  • Walgreens
  • Walmart

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Retail Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Retail Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Retail Drug Market Dynamics
  1. 2.1 Retail Drug Industry Trends
  2. 2.2 Retail Drug Industry Drivers
  3. 2.3 Retail Drug Industry Opportunities and Challenges
  4. 2.4 Retail Drug Industry Restraints
3 Retail Drug Market by Company
  1. 3.1 Global Retail Drug Company Revenue Ranking in 2025
  2. 3.2 Global Retail Drug Revenue by Company (2021-2026)
  3. 3.3 Global Retail Drug Company Ranking (2024-2026)
  4. 3.4 Global Retail Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Retail Drug Company Product Type and Application
  6. 3.6 Global Retail Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Retail Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Retail Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Retail Drug Market by Type
  1. 4.1 Retail Drug Type Introduction
  2. 4.1.1 Generic Drug
  3. 4.1.2 OTC Drug
  4. 4.1.3 Others
  5. 4.2 Global Retail Drug Sales Value by Type
  6. 4.2.1 Global Retail Drug Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Retail Drug Sales Value by Type (2021-2032)
  8. 4.2.3 Global Retail Drug Sales Value Share by Type (2021-2032)
5 Retail Drug Market by Application
  1. 5.1 Retail Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Hoem Use
  5. 5.2 Global Retail Drug Sales Value by Application
  6. 5.2.1 Global Retail Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Retail Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Retail Drug Sales Value Share by Application (2021-2032)
6 Retail Drug Regional Value Analysis
  1. 6.1 Global Retail Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Retail Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Retail Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Retail Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Retail Drug Sales Value (2021-2032)
  7. 6.3.2 North America Retail Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Retail Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Retail Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Retail Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Retail Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Retail Drug Sales Value (2021-2032)
  16. 6.6.2 South America Retail Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Retail Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Retail Drug Sales Value Share by Country, 2025 VS 2032
7 Retail Drug Country-level Value Analysis
  1. 7.1 Global Retail Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Retail Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Retail Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Retail Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Retail Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Retail Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Retail Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Retail Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Retail Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Retail Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Retail Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Retail Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Retail Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Retail Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Retail Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Retail Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Retail Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Retail Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Retail Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Retail Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Retail Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Retail Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Retail Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Retail Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Retail Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Retail Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Retail Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Retail Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Retail Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Retail Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Retail Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Retail Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Retail Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Retail Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Retail Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Retail Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Retail Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Retail Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Retail Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Retail Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Retail Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Retail Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Retail Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Retail Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Retail Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Retail Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Retail Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Retail Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Retail Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Retail Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Retail Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Retail Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Retail Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Retail Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Retail Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Retail Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Retail Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Retail Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Retail Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Retail Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Retail Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Retail Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Retail Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Retail Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Retail Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Retail Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Retail Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Retail Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Retail Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Retail Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Retail Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Retail Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Retail Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Retail Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Retail Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Retail Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Retail Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Retail Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Retail Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Retail Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Retail Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Retail Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Retail Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Retail Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Retail Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Retail Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Retail Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Retail Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CVS Caremark
  2. 8.1.1 CVS Caremark Company Information
  3. 8.1.2 CVS Caremark Business Overview
  4. 8.1.3 CVS Caremark Retail Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CVS Caremark Retail Drug Product Portfolio
  6. 8.1.5 CVS Caremark Recent Developments
  7. 8.2 Rite Aid
  8. 8.2.1 Rite Aid Company Information
  9. 8.2.2 Rite Aid Business Overview
  10. 8.2.3 Rite Aid Retail Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Rite Aid Retail Drug Product Portfolio
  12. 8.2.5 Rite Aid Recent Developments
  13. 8.3 Target
  14. 8.3.1 Target Company Information
  15. 8.3.2 Target Business Overview
  16. 8.3.3 Target Retail Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Target Retail Drug Product Portfolio
  18. 8.3.5 Target Recent Developments
  19. 8.4 Walgreens
  20. 8.4.1 Walgreens Company Information
  21. 8.4.2 Walgreens Business Overview
  22. 8.4.3 Walgreens Retail Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Walgreens Retail Drug Product Portfolio
  24. 8.4.5 Walgreens Recent Developments
  25. 8.5 Walmart
  26. 8.5.1 Walmart Company Information
  27. 8.5.2 Walmart Business Overview
  28. 8.5.3 Walmart Retail Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Walmart Retail Drug Product Portfolio
  30. 8.5.5 Walmart Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst